Fate Therapeutics, Inc. (FATE)
1.09
+0.04
(+3.81%)
USD |
NASDAQ |
Dec 10, 16:00
1.10
+0.01
(+0.92%)
After-Hours: 20:00
Fate Therapeutics Price: 1.09 for Dec. 10, 2025
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| NovaBay Pharmaceuticals, Inc. | 2.42 |
| Palatin Technologies, Inc. | 25.62 |
| Theriva Biologics, Inc. | 0.2215 |
| Oragenics, Inc. | 0.9679 |
| NanoViricides, Inc. | 1.32 |
Price Related Metrics
| PS Ratio | 18.09 |
| Price to Book Value | 0.5372 |
| Earnings Yield | -121.0% |
| Market Cap | 125.73M |